Thursday, April 17, 2025

Technology | 2020.06.13

New Late-Breaking Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1C Levels in People with Type 2 Diabetes Using Insulin or Not

ABBOTT PARK, Ill., June 13, 2020 /PRNewswire/ -- Today, Abbott (NYSE: ABT) announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world\'s leading3 continuous glucose monitoring (CGM) technology, is associated with significant reduction in hemoglobin A1c...

 

For more information, please visit
https://prnmedia.prnewswire.com:443/news[...]-insulin-or-not-301075390.html

You need to login to post comments.

Feed last updated 2025/04/30 @6:04 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News